Atrial fibrillation with RVR: Difference between revisions
| Line 70: | Line 70: | ||
== Evidence of preexcitation == | == Evidence of preexcitation == | ||
#Initial therapy is aimed at reversion to sinus rhythm | |||
##Unstable -> urgent cardioversion | |||
###DC cardioversion | |||
###Pharmacologic cardioversion | |||
####Procainamide | |||
#####20-50 mg/min until arrhythmia is controlled, hypotension occurs, QRS complex widens by 50% of original width, or total of 17 mg/kg is given; followed by continuous infusion of 1-4 mg/min | |||
##Stable -> try to avoid cardioversion without adequate anticoagulation | |||
##Avoid AV nodal agents | |||
== See Also == | == See Also == | ||
Revision as of 12:52, 12 March 2011
Unstable (Cardioversion)
Indications
- Ischemic CP
- SBP < 90
- Acute pulmonary edema
- AMS
Above must be 2/2 RVR (i.e. if pulse is <130 look for other cause of above signs)
- Sedate: Versed / Ativan / Fentanyl
- Initial 100J monophasic or 50-70j biphasic synchronized cardioversion
Stable but Symptomatic (Rate Control)
Goal < 110bpm1
Be careful that you are not slowing down a normal physiologic response!
- RVR in AF may be an appropriate response to fever, hypovolemia, hemorrhage, hypoxemia, withdrawal
No evidence that pharmacological rate control has any adverse influence on LV dysfunction
Calcium-Channel Blockers
- Preferred in pts with chronic lung disease or low EF
- Contraindications
- Decompensated heart failure
- Preexcitation
- Significant hypotension
Diltiazem
- Bolus 0.25 mg/kg (average adult dose 20mg) over 2 min
- If, after 15 minutes the first dose is tolerated but inadequate, re-bolus 0.35 mg/kg (average adult dose 25 mg)
- If pt responds to 1st or 2nd bolus start infusion at 5-15mg/hr
- Takes 2-5 minutes to work, last 1-4 hours
- 94% responive
- If effective, can start PO dilt at 30mg QID
Beta-Blockers
- Particularly useful with a fib associated with exercise, after an acute MI, or with thyrotoxicosis
- Contraindicated in COPD, low EF CHF
- PO load with MTP 25-50mg following successful rate control with IV
Metoprolol
- 2.5-5mg IVP over 2min q5 min up to 3 doses
Esmolol
- Use if unsure whether pt will tolerate a BB (duration of action is only 10-20min)
- Bolus 0.5 mg/kg over one minute, followed by 50 µg/kg/min
- If, after 4 minutes response is inadequate, re-bolus followed by infusion of 100 µg/kg/min
- If, after 4 minutes response is still inadequate, try final bolus followed by infusion of 150 µg/kg/min
- If necessary, infusion can be increased to maximum of 200 µg/kg/min after another four minutes
Digoxin
- Consider as initial therapy for pts with LV dysfunction who:
- Do not achieve rate control targets on beta blockers alone
- Cannot tolerate addition of or increased doses of a beta blocker due to acute decompensated HF
- Would have digoxin added anyway to improve CHF symptoms independent of AF
- Consider as initial therapy in pts with severe hypotension
- Consider as 2nd agent in pts in whom IV BB or IV CCB has failed to control their rate
- May take up to 6-8 hours to work
- Dosing
- 0.25 mg IV q2hr up to 1.5 mg, then 0.125-0.25 mg PO or IV QD
- Adjust dose in presence of renal failure, amiodarone, etc
Amiodarone
- Consider for use in pts with decompensated heart failure or those with accessory pathways
- 2nd-line agent for chronic rate control when BBs and CCBs, alone, combined, or when used with digoxin, are ineffective
- Load 5-7 mg/kg IV over 30 min; then 1200 mg over 24 h via continuous infusion or in divided oral doses
Stable and Asymptomatic
If mild or no symptoms and pulse only mildly elevated (<120bpm), ok to manage with PO meds
Evidence of preexcitation
- Initial therapy is aimed at reversion to sinus rhythm
- Unstable -> urgent cardioversion
- DC cardioversion
- Pharmacologic cardioversion
- Procainamide
- 20-50 mg/min until arrhythmia is controlled, hypotension occurs, QRS complex widens by 50% of original width, or total of 17 mg/kg is given; followed by continuous infusion of 1-4 mg/min
- Procainamide
- Stable -> try to avoid cardioversion without adequate anticoagulation
- Avoid AV nodal agents
- Unstable -> urgent cardioversion
See Also
Atrial Fibrillation (Gen)
Source
1/30/06 DONALDSON (adapted from Lampe), UpToDate, Niemann lecture
1RACE II study
